Yang C C, Chan J Y, Pan J T, Chan S H
Institute of Pharmacology, National Yang-Ming Medical College, Taipei, Taiwan, ROC.
Brain Res. 1994 Feb 28;638(1-2):169-74. doi: 10.1016/0006-8993(94)90646-7.
We previously reported that chronic central administration of angiotensin III (AIII) fails to produce sustained drinking behavior in spontaneously hypertensive rats (SHR), possibly because of the development of early desensitization of the angiotensin receptors. The present study extended these findings to the cellular level, using brain-slice preparation from Wistar-Kyoto rats (WKY) and SHR, in conjunction with single-neuron recording in the subfornical organ (SFO), a target site for angiotensin II-induced drinking. We found that a majority of the SFO neurons studied (13/18 in WKY, 20/28 in SHR) responded in a dose-related manner to AIII, given in the range of 10(-6)-10(-5) M. This excitation was receptor-specific, since it was reversed by Ile7-AIII (10(-4)-10(-3) M), the selective AIII antagonist. Bestatin (10(-5)-10(-4) M), an aminopeptidase B inhibitor, did not discernibly affect basal spike frequency when delivered alone. Nevertheless, given in combination with the heptapeptide, bestatin reduced the intensity and duration of SFO neuronal response in WKY to the higher dose (10(-5) M), and in SHR to both doses (10(-6) or 10(-5) M), of AIII. These data suggest that the SFO may also be a central site of action for AIII. Moreover, prolonging the action of AIII by protecting it from being metabolized with bestatin may produce desensitization of the angiotensin receptors on SFO neurons. This was particularly so in the SHR, which are thought to be defective in the degradation of the heptapeptide in the brain.
我们之前报道过,对自发性高血压大鼠(SHR)长期进行中枢给予血管紧张素III(AIII)未能产生持续性饮水行为,这可能是由于血管紧张素受体早期脱敏的发展所致。本研究将这些发现扩展到细胞水平,使用来自Wistar - Kyoto大鼠(WKY)和SHR的脑片标本,并结合穹窿下器官(SFO)中的单神经元记录,SFO是血管紧张素II诱导饮水的靶位点。我们发现,所研究的大多数SFO神经元(WKY中为13/18,SHR中为20/28)对10(-6)-10(-5) M范围内的AIII呈剂量相关反应。这种兴奋是受体特异性的,因为它可被选择性AIII拮抗剂Ile7 - AIII(10(-4)-10(-3) M)逆转。氨肽酶B抑制剂贝司他汀(10(-5)-10(-4) M)单独给药时对基础放电频率没有明显影响。然而,与七肽联合给药时,贝司他汀降低了WKY中SFO神经元对较高剂量(10(-5) M)AIII的反应强度和持续时间,以及SHR中对两种剂量(10(-6)或10(-5) M)AIII的反应强度和持续时间。这些数据表明,SFO也可能是AIII的一个中枢作用位点。此外,通过用贝司他汀保护AIII不被代谢来延长其作用时间,可能会使SFO神经元上的血管紧张素受体脱敏。在SHR中尤其如此,因为SHR被认为在脑中七肽的降解方面存在缺陷。